Zembrace Symtouch
Product Images NDC 67857-809

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Zembrace Symtouch (NDC 67857-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Promius Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan-structure (Zembrace 01)

Chemical structure diagram of the active ingredient in ZEMBRACE SymTouch (as indicated by the product data), showing a complex organic molecule with indole and sulfonamide groups and an associated molecule with carboxyl groups.*

FDA Label Image

Ifu1 (Zembrace 02)

FDA Label Image

Ifu2 (Zembrace 03)

An illustration diagram of the ZEMBRACE SymTouch autoinjector device, labeling its components including the red cap, yellow needle guard, medicine viewing window, red plunger rod, and the device body with product name ZEMBRACE SymTouch visible.*

FDA Label Image

Ifu3 (Zembrace 04)

An instructional illustration showing a close-up of a person's eye and hand holding the ZEMBRACE SymTouch injector pen. The pen's expiration date location is highlighted with dotted lines pointing to the label area marked 'EXP: Mo./Yr.'*

FDA Label Image

Ifu4 (Zembrace 05)

Illustration showing a close-up of an eye looking at a test window on a ZEMBRACE SymTouch device, highlighting a result indicator with a red line.*

FDA Label Image

Ifu5 (Zembrace 06)

An instructional illustration showing the components included with ZEMBRACE SymTouch, a product by Promius Pharma, LLC. The image displays the ZEMBRACE SymTouch injector pen along with an alcohol swab, a sterile cotton ball or gauze, and a puncture-resistant sharps container marked with a biohazard symbol.*

FDA Label Image

Ifu6 (Zembrace 07)

An instructional diagram showing a human figure highlighting recommended injection sites with green marks on the upper arm, thigh, and abdomen. The label points to these areas indicating "Injection Sites." No specific medication information is visible in the image.*

FDA Label Image

Ifu7 (Zembrace 08)

An illustration showing a hand holding an alcohol swab wiping the skin on another arm in a circular motion. This image appears instructional, demonstrating how to clean the skin before an injection.*

FDA Label Image

Ifu8 (Zembrace 09)

Instructional illustration depicting a hand holding a ZEMBRACE SymTouch autoinjector pen, aligning it to insert a small cap or cover piece. A close-up inset highlights the area of connection on the device.*

FDA Label Image

Ifu9 (Zembrace 10)

Illustration showing a hand holding the ZEMBRACE SymTouch autoinjector device against the skin, demonstrating the proper injection technique. The device is depicted with a window and a yellow cap, positioned for subcutaneous injection.*

FDA Label Image

Ifu10 (Zembrace 11)

An instructional illustration showing how to use the ZEMBRACE SymTouch autoinjector. It depicts a hand holding the injector, pressing it down with audible clicks indicated as "CLICK 1" and "CLICK 2" while demonstrating to hold and then wait for a count of five seconds before releasing.*

FDA Label Image

Ifu11 (Zembrace 12)

An instructional illustration showing a hand holding a ZEMBRACE SymTouch autoinjector device with a yellow needle guard locked over the needle. An upward pointing arrow below the device indicates the injection direction over a surface likely representing skin.*

FDA Label Image

Ifu12 (Zembrace 13)

An instructional illustration showing a hand holding the ZEMBRACE SymTouch autoinjector with an enlarged view of the dose window indicating the presence of the medication inside. The image demonstrates how to check the dose display during injection.*

FDA Label Image

Ifu13 (Zembrace 14)

An instructional illustration showing a hand disposing of a used ZEMBRACE SymTouch autoinjector into a red biohazard sharps container labeled with a biohazard symbol. This image likely demonstrates proper disposal method for the product.*

FDA Label Image

Ifu14 (Zembrace 15)

FDA Label Image

Auto-injector Label (Zembrace 16)

ZEMBRACE SymTouch 3 mg autoinjector label for sumatriptan injection, subcutaneous. The label includes dosage information with 0.5 mL solution containing 4.2 mg sumatriptan succinate equivalent to 3 mg sumatriptan base. Distributed by Promius Pharma, LLC. Contains storage instructions and a barcode with NDC 67857-809-37.*

FDA Label Image

4-count Carton Label (partition) (Zembrace 17)

This is a flat layout of the folding carton for ZEMBRACE SymTouch by Promius Pharma, LLC. The carton has multiple scored fold lines and includes red tear-to-open tabs. While the image does not show dosage strength or detailed text, it clearly depicts the structural design for the packaging of this drug product.*

FDA Label Image

4-count Carton Label (interior) (Zembrace 18)

Printed carton packaging label for ZEMBRACE SymTouch sumatriptan injection, showing the product name in red and yellow with a logo, a prompt to read patient instructions for the SymTouch injector, and a QR code. The website www.zembrace.com is also visible. The label is presented flat, showing fold lines.*

FDA Label Image

4-ct Carton Label (exterior) (Zembrace 19)

Box label for ZEMBRACE SymTouch (sumatriptan injection) 3 mg autoinjector by Promius Pharma. The packaging shows product name, active ingredient, and strength as 3 mg sumatriptan injection in a 0.5 mL prefilled syringe. It includes storage instructions to keep between 20°C to 25°C and protect from light. Distribution and manufacturing information is provided, along with an image of the autoinjector.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.